Bank of New York Mellon Corp Reduces Stock Position in ASP Isotopes Inc. (NASDAQ:ASPI)

Bank of New York Mellon Corp cut its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 6.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 125,874 shares of the company’s stock after selling 8,512 shares during the quarter. Bank of New York Mellon Corp’s holdings in ASP Isotopes were worth $570,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Philadelphia Financial Management of San Francisco LLC grew its holdings in ASP Isotopes by 158.3% during the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after buying an additional 607,893 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of ASP Isotopes by 42.7% in the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after acquiring an additional 334,836 shares during the period. Walleye Capital LLC bought a new position in shares of ASP Isotopes in the third quarter valued at approximately $536,000. State Street Corp grew its stake in ASP Isotopes by 12.8% during the third quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after acquiring an additional 96,604 shares in the last quarter. Finally, Barclays PLC increased its holdings in ASP Isotopes by 438.5% during the 3rd quarter. Barclays PLC now owns 72,330 shares of the company’s stock worth $201,000 after acquiring an additional 58,897 shares during the period. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Stock Up 12.9 %

Shares of NASDAQ:ASPI opened at $4.73 on Friday. The firm has a fifty day moving average price of $5.04 and a two-hundred day moving average price of $4.89. The company has a market cap of $337.67 million, a price-to-earnings ratio of -7.75 and a beta of 3.66. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes Inc. has a one year low of $1.86 and a one year high of $9.33.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.